CN Patent
CN103910698B — 卡巴他赛丙酮合物及其结晶
Assigned to Shanghai Institute of Pharmaceutical Industry · Expires 2016-01-20 · 10y expired
What this patent protects
本发明涉及卡巴他赛丙酮合物及其结晶,具体地说,本发明涉及卡巴他赛丙酮合物及其结晶、制备该丙酮合物及其结晶的方法、含有该丙酮合物及其结晶的药物组合物、以及其在制备抗肿瘤药物中的用途。本发明的卡巴他赛丙酮合物及其结晶具有理化性质优异、稳定性好、制备工艺简便、更适于工业化规模制备等优点。
USPTO Abstract
本发明涉及卡巴他赛丙酮合物及其结晶,具体地说,本发明涉及卡巴他赛丙酮合物及其结晶、制备该丙酮合物及其结晶的方法、含有该丙酮合物及其结晶的药物组合物、以及其在制备抗肿瘤药物中的用途。本发明的卡巴他赛丙酮合物及其结晶具有理化性质优异、稳定性好、制备工艺简便、更适于工业化规模制备等优点。
Drugs covered by this patent
- Jevtana Kit (cabazitaxel) · Accord Hlthcare
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.